Search results
Results From The WOW.Com Content Network
But on the board of directors page on 23andMe’s website, there’s now just one photo: Wojcicki, alone. Correction: This story has been updated to reflect that Steve Schoch left the company in 2022.
DNA-testing service 23andMe is making substantial efforts to nurse its feeble genetic core back to health. The company will lay off 40% of its workforce, over 200 employees, and cull its therapy ...
(Reuters) - The independent directors of genetic testing firm 23andMe said on Tuesday they have resigned from the company's board after not receiving a satisfactory take-private offer from CEO ...
The sudden resignation spurred headlines in the media about 23andMe's unsteady footing. The company sought to address this imbalance by appointing three new independent directors to its board in ...
All seven independent directors of 23andMe’s board resigned on Tuesday, citing disagreements over the chief executive’s plan to take the company private. The departures leave just one sitting ...
Following a monthslong battle over CEO Anne Wojcicki’s plans to take 23andMe private, all seven independent members of its board resigned en masse Tuesday.. The move is almost certainly the ...
All of 23andMe's independent directors resigned from its board this week, a rare move that marks the latest challenge for the genetic-testing company. The resignations follow drawn-out ...
Genetic testing firm 23andMe said on Monday it is reducing about 40%, or 200 employees, from its workforce and discontinuing further development of all its therapies as part of a restructuring ...